RE: Told you so...5 Oct 2025 19:07
Issued share capital: 258,779,463 Ordinary Shares of 1p nominal value.
The percentage of Ordinary Shares not being held in public hands is 16.1%.
Shares held in treasury: Nil Ordinary shares.
Significant Shareholders
As at 01 October 2025
Significant shareholders that hold more than 3% of the share capital of SkinBioTherapeutics plc are detailed below:
Number Ordinary Shares %
Mark Dixon 24,887,876 9.62%
OptiBiotix Health Plc 18,778,137 7.26%
David Brierwood 16,416,813 6.34%
Tyndall Investment Management 16,235,259 6.27%
Seneca Partners Limited 13,586,408 5.25%
Unicorn Asset Management 7,894,737 3.05%
Director Shareholders
Martin Hunt* 560,417 0.22%
Stuart John Ashman 276,804 0.11%
Dr Cathy Prescott 181,112 0.07%
Danielle Bekker 43,750 0.02%
*Martin Hunt’s shareholding is held through Invictus Management Limited, a company controlled by Mr Hunt. Of the 560,417 shares held by Invictus Management Limited 11,112 are held on behalf of Louise Hunt and 11,111 are held on behalf of Oliver Hunt.
so no change notified from any other major shareholder other than MD
and with 83.9% continuing to be held in public hands
shychap determines that
Meanwhile, Mark Dixon has acquired 25m shares from somewhere, only a small proportion of which could have been sold by PIs
jees he has built up his holding over an extended period of time from ...
he will soon if not by now become a substantial shareholder
Any person who holds any legal or beneficial interest directly or indirectly in 10% or more of any class of AIM security (excluding treasury shares)
and hence his shareholding will become not in public hands
mol